Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120205) titled 'Research and Application of a Precise Assessment and Individualized Diagnosis and Treatment System for Dementia Based on Blood Biomarkers - Construction of a Multi-modal Digital Assessment Platform' on March 10.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Yuebei People's Hospital
Condition:
Alzheimer's Disease
Vascular Dementia
Mild Cognitive Impairment
Intervention:
Patient group:none
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-10
Target Sample Size: Patient group:90;Control group:90;
Countries of Recruitment:
China
To know ...